Caspian Journal of Internal Medicine
Babol University of Medical Sciences
Sat, Dec 21, 2024
[Archive]
Volume 13, Issue 1 (Winter 2022)
Caspian J Intern Med 2022, 13(1): 136-138 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hadinezhad P, Hosseini H. Sertraline-induced rectal bleeding and anal pain (a rare case presentation). Caspian J Intern Med 2022; 13 (1) :136-138
URL: http://caspjim.com/article-1-2078-en.html
URL: http://caspjim.com/article-1-2078-en.html
Department of Psychiatry, Psychiatry Research and Behavioral Sciences Institute, Mazandaran University of Medical Sciences, Sari, Iran , hosseinish20@gmail.com
Abstract: (3174 Views)
Background: Selective serotonin reuptake inhibitors (SSRIs) have proven more problematic in terms of some side effects than the original clinical trials suggested. Sertraline may displace warfarin from plasma proteins and may increase the prothrombin time. The aim of this study was to report a rare case of the sertraline- induced severe anal pain and rectal bleeding without concurrent of taking any other drugs including non-steroidal anti-inflammatory drugs (NSAIDs).
Case Presentation: Here we report a case of a 31-year old married man who referred to a psychiatrist with depressive disorder and started to take sertraline up to 400 mg daily, thereafter the patient reported severe anal pain and bleeding. Other etiologies of this side effect were evaluated with Naranjo evaluation scale and rolled out. The patient did not report any anal pain or bleeding after eight months of stopping sertraline.
Conclusion: Reported from sertraline, the psychiatrists must be more cautious when prescribing sertraline and monitor the patient properly for a long time to ensure these rare adverse effects and complications do not happen.
Case Presentation: Here we report a case of a 31-year old married man who referred to a psychiatrist with depressive disorder and started to take sertraline up to 400 mg daily, thereafter the patient reported severe anal pain and bleeding. Other etiologies of this side effect were evaluated with Naranjo evaluation scale and rolled out. The patient did not report any anal pain or bleeding after eight months of stopping sertraline.
Conclusion: Reported from sertraline, the psychiatrists must be more cautious when prescribing sertraline and monitor the patient properly for a long time to ensure these rare adverse effects and complications do not happen.
Type of Study: case report |
Subject:
psychiatry
Received: 2019/10/12 | Accepted: 2020/06/14 | Published: 2022/01/20
Received: 2019/10/12 | Accepted: 2020/06/14 | Published: 2022/01/20
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
